AAPS Addresses “Infodemic,” Scientific Credibility and the Public On TV

A man wearing a suit, a man in a patterned shirt smiling, and a woman wearing pearls.
November 4, 2022
Leaders from the American Association of Pharmaceutical Scientists (AAPS), including the College of Pharmacy's Dr. Robert O. (Bill) Williams III, address the “infodemic” and AAPS’ role in evaluating and bringing attention to credible science on a November 5 episode of "Advancements with Ted Danson."

College of Pharmacy Researchers Share Latest Findings on Novel Drug Delivery Technology

Five nasal inhalers with their caps on.
October 31, 2022
Researchers in the lab of Dr. Robert O. (Bill) Williams III, Division Head and Professor of Molecular Pharmaceutics and Drug Delivery at the College of Pharmacy, are advancing an innovative platform technology known as Thin Film Freezing, which could revolutionize administration, distribution and access to both vaccines and therapies.

Summer Programs of Innovation and Diversity

LEADER/PEPP Program participants and leaders sitting together at an outdoor table for lunch.
September 6, 2022
This summer, the office of Diversity, Equity, Accessibility, and Inclusion (DEAI), hosted two intensive summer research programs: Project Engage Pharmacy Program (PEPP) Camp and the Leadership Through Engagement For the Advancement of Diverse Educational Research (LEADER) Program.

Celebrating the Latest Awards, Appointments and Achievements from the UT Pharmacy Community

Pharmacy building on UT campus
July 5, 2022
From student scholarships to national recognition awards to prestigious appointments, the UT Pharmacy community has a lot to celebrate and be proud of right now.

Williams Talks to KXAN About How Thin Film Freezing Can Help Treat COVID Patients

A man wearing glasses.
July 30, 2021
Division Head and Professor of Molecular Pharmaceutics and Drug Delivery Dr. Bill Williams was on KXAN News to talk about promising new data from TFF Pharmaceuticals and Augmenta Bioworks. The companies plan to develop Dr. Williams' thin film freezing technology to better deliver antibody treatment directly to the lungs of COVID patients.

Ridings-Myhra Earns TSHP Distinguished Service Award

TSHP.
April 16, 2021
Assistant Dean for Experiential and Professional Affairs Jennifer L. Ridings-Myhra, M.Ed., R.Ph. is 2021's recipient of the Distinguished Service Award from the Texas Society of Health-System Pharmacists (TSHP). It is the highest honor TSHP can bestow on an individual.

TxCORE Research Wins PhRMA Foundation Award

Three people smiling.
April 1, 2021
Three researchers from the College of Pharmacy won an award from the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation. Leticia R. Moczygemba, Pharm.D., Ph.D., Carolyn M. Brown, Ph.D. and Michael Johnsrud, Ph.D., R.Ph. were awarded $5,000 from the PhRMA Foundation for their proposal to advance racial and ethnic representation in value assessments.

Williams Wants to Turn COVID-19 Vaccine into Powder to Help with Storage and Distribution

A powder in a vial.
November 25, 2020
Molecular Pharmaceutics and Drug Delivery Professor Robert O. (Bill) Williams III, Ph.D. talks to CBS Austin about the potential for his thin film freezing technology to increase the shelf life of COVID-19 vaccines when they become available.

Peppas to Receive Prestigious Oesper Award in Honor of Contributions to Chemistry

A smiling man standing in front of a bookshelf.
November 4, 2020
Nicholas A. Peppas, Sc.D. has been honored with the 2020 Oesper Award from the University of Cincinnati’s Chemistry Department and the Cincinnati Section of the American Chemical Society for his outstanding accomplishments in and contributions to science. The award recognizes his work in biomaterials, drug delivery, bionanotechnology, and nanomaterials.

Live Subject Testing Shows Promising Delivery Method for COVID-19 Antiviral Treatment

A microscopic image.
September 23, 2020
Live subject testing results from the Williams Lab show that dry powder inhalation could be a potent and effective delivery method of the antiviral remdesivir to treat patients affected by COVID-19.